(+/-)-4-HYDROXY-4-[2-(ADENIN-9-YL)-ETHYL]-2,3-DIMETHOXY-DELTA(ALPHA,BETA)-BUTENOLIDE
Compound with spectra: 1 NMR
![(+/-)-4-HYDROXY-4-[2-(ADENIN-9-YL)-ETHYL]-2,3-DIMETHOXY-DELTA(ALPHA,BETA)-BUTENOLIDE](/api/compound/9Z8jVZB0xNX.png?ph=true&h=300&w=458 "(+/-)-4-HYDROXY-4-[2-(ADENIN-9-YL)-ETHYL]-2,3-DIMETHOXY-DELTA(ALPHA,BETA)-BUTENOLIDE")
| SpectraBase Compound ID | 9Z8jVZB0xNX |
|---|---|
| InChI | InChI=1S/C13H15N5O5/c1-21-8-9(22-2)13(20,23-12(8)19)3-4-18-6-17-7-10(14)15-5-16-11(7)18/h5-6,20H,3-4H2,1-2H3,(H2,14,15,16)/t13-/m1/s1 |
| InChIKey | KSEQDTJXLIHGGT-CYBMUJFWSA-N |
| Mol Weight | 321.29 g/mol |
| Molecular Formula | C13H15N5O5 |
| Exact Mass | 321.107319 g/mol |
| Enantiomer InChIKey | KSEQDTJXLIHGGT-ZDUSSCGKSA-N |
| Racemate InChIKey | KSEQDTJXLIHGGT-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
N(6)-Methyl-9-(2,3-O-isopropylidene-D-ribityl)adenine
9-[3,5,6-TRIDEOXY-6E-FLUORO-BETA-D-ERYTHRO-HEX-5-ENOFURANOSYL]-ADENINE
butyric acid [(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-tetrahydrofuran-2-yl]methyl ester
acrylic acid [(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-tetrahydrofuran-2-yl]methyl ester
5'-ACETYL-3'-DEOXY-ADENOSINE
(Z)-9-(3,5-DIDEOXY-5-FLUORO-BETA-D-GLYCERO-PENT-4-ENOFURANOSYL)-ADENINE;COMPUOND-#13AZ
(E)-9-(3,5-DIDEOXY-5-FLUORO-BETA-D-GLYCERO-PENT-4-ENOFURANOSYL)-ADENINE;COMPUOND-#13AE
5'-O-CARBAZOYL-2'-DEOXYADENOSINE
(Z)-3-(6-Amino-9H-purin-9-yl)-4-hydroxy-4-methyl-2-hexenenitrile
2'-DEOXYADENOSIN-5'-YL_H-PHOSPHONOTHIOATE_TRIETHYLAMMONIUM_SALT;DIASTEREOMER_1
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Biological Evaluation of Purine-Containing Butenolides | Journal of Medicinal Chemistry | 2001 |